ClinicalTrials.Veeva

Menu

Long Term Impact of COVID-19

M

Medisch Spectrum Twente

Status

Completed

Conditions

COVID-19
Long COVID-19
Post-COVID-19 Syndrome

Treatments

Other: Observational patient reported outcomes

Study type

Observational

Funder types

Other

Identifiers

NCT05813574
Long COVID

Details and patient eligibility

About

COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has a devastating effect on human lives, including over 6.6 million death as of November 2022. Furthermore, many individuals continue to experience persisting sequelae after the initial infection. Little is known about the impact of undergoing COVID-19 hospitalisation. Hence, the investigators propose an observational longitudinal study in a cohort of COVID-19 survivors after hospital discharge, to examine their perspectives on their health, health-related quality of life, and persistence of common COVID-19 symptoms, such as fatigue, dyspnoea and anxiety. Potential influencing socio-demographic and biological factors will additionally assessed.

Enrollment

835 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ages ≥18 years
  • PCR-confirmed SARS-CoV-2 infection and hospital admission
  • Proficiency in Dutch
  • Providing informed consent

Exclusion criteria

  • None

Trial design

835 participants in 1 patient group

COVID-19 survivors
Description:
COVID-19 survivors: patients (≥18 years old) who were tested positive for SARS-CoV-2 infection as confirmed by polymerase-chain-reaction (PCR) testing and were subsequently hospitalised, were followed after discharge from hospitals in Enschede (MST), Hengelo or Almelo (ZGT).
Treatment:
Other: Observational patient reported outcomes

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems